Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection

Folia Microbiologica

Volumn 45, Issue , 2000, Pages 7-28

  Rajcani J ^a   Durmanova V ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VIRUS TYPE 1 PROTEIN VP22; HERPES SIMPLEX VIRUS, TYPE 1 PROTEIN ICP4; ICP27 PROTEIN, HUMAN HERPESVIRUS 1; ICP47 PROTEIN, HERPES SIMPLEX VIRUS; IMMEDIATE EARLY PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; VIRUS PROTEIN; VMW110 PROTEIN, HUMAN HERPESVIRUS 1;

ANIMAL; GENETIC TRANSCRIPTION; GENETICS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; METABOLISM; NERVE CELL; PHYSIOLOGY; REVIEW; VIROLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

ANIMALS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS PROTEIN VMW65; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; NEURONS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0043028029     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02817445     Document Type: Article

References (172)

1. AHN K., MEZER T.H., UEBEL S., SEMPE P., DJABALLAH H., ZANG Y., PETERSON P.A., FRUH K., TAMPE R.: Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15, 3247-3255 (1996).
2. BACHENHEIMER S.L., VIDYARTHI S., JOSEPH G., MCLEAN T.I.: Efficiency of herpes simplex virus replication, dependent on p107 and p130 regulation of E2F a cyclin kinases, p. 36 in 23rd International Herpesvirus Workshop, York (UK) 1998.
3. BATES P.A., DELUCA N.A.: The polyserine tract of herpes simplex virus ICP4 is required for normal viral gene expression and growth in murine trigeminal ganglia. J. Virol. 72, 7115-7124 (1998).
4. BATCHELOR A.H., O'HARE P.: Regulation and cell-type specific activity of a promoter located upstream of the latency associated transcript of herpes simplex virus type 1. J. Virol. 64, 3269-3279 (1990).
5. BLOCK T.M., SPIVACK J.G., STEINER I., DESHMANE S., MCINTOSH M.T., LIRETTE R.P., FRASER N.W.: A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection. J. Virol. 64, 3417-3426 (1990).
6. BLOOM D.C., DEVI-RAO G.B., HILL J.M., STEVENS J.G., WAGNER E.K.: Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J. Virol. 68, 1283-1292 (1994)
7. BOEHMER P.E., LEHMAN I.R.: Herpes simplex virus DNA replication. Ann.Rev.Biochem. 66, 347-384 (1997).
8. BROWN C.R., NAKAMURA M.S., MOSCA J.D., HAYWARD G.S., STRAUS S.E., PERERA L.P.: Herpes simplex virus transregulatory protein ICP27 stabilizes and binds to 3′ ends of labile mRNA. J. Virol. 69, 7187-7195 (1995).
9. BRUNI R., FINESCHI B., OGLE O. W., ROIZMAN B.: A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and is recruited to the nucleus after infection. J. Virol. 73, 3810-3817 (1999).
10. BRUNI R., ROIZMAN B.: Herpes simplex virus 1 regulatory protein ICP22 interacts with a new cell cycle-regulated factor and accumulates in a cell cycle-dependent fashion in infected cells. J. Virol. 72, 8525-8531 (1998).
11. BZIK D.J., PRESTON CM.: Analysis of DNA sequences which regulate the transcription of herpes simplex virus immediate-early gene 3: DNA sequences required for enhancer-like activity and response to transactivation by a virion polypeptide. Nucl.Acids Res. 14, 929-943 (1986).
12. CAI W., SCHAFFER P.A.: Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early and late genes in productively infected cells. J. Virol. 66, 2904-2915 (1992).
13. CANTIN E., TANAMACHI B., OPENSHAW H.: Role for γ-interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73, 3418-3423 (1999).
14. CARROZZA M.J., DELUCA N.A.: Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol.Cell Biol. 16, 3085-3093 (1996).
15. CARROZZA M.J., DELUCA N.A: The high mobility group protein 1 is a coactivator of herpes simplex virus ICP4 in vitro. J. Virol. 72, 6752-6757 (1998).
16. CHEN J., SILVERSTEIN S.: Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J. Virol. 66, 2916-2927 (1992).
17. CHEN S.H., KRAMER M.F., SCHAFFER P.A., COEN D.M.: A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 71, 5878-5884 (1997).
18. CHOU J., KERN E.R., WHITLEY R.J., ROIZMAN B.: Mapping of the herpes simplex virus 1 neurovirulence γ-34.5 gene nonessential for growth in cell culture. Science 252, 1262-1266 (1990).
19. DAVIDO D.J., LEIB D.A.: Analysis of the basal and inducible activities of the ICP0 promotor of herpes simplex virus type 1. J.Gen. Virol. 79, 2093-2098 (1998).
20. DESAI P., RAMAKRISHNAN R., LIN Z.W., OSAK B., GLORIOSO J.C., LEVINE M.: The RR1 gene of herpes simplex virus type 1 is uniquely irons activated by ICP0 during infection [published erratum appears in J. Virol. 68, 1264, 1994]. J. Virol. 67, 6125-6135 (1993).
21. DESAI P.J., SCHAFFER P.A., MINSON A.C.: Excretion of non-infectious particles lacking glycoprotein H by a ts-mutant of herpes simplex virus type 1: Evidence that gH is essential for virion infectivity. J.Gen. Virol. 69, 1147-1156 (1988).
22. DESHMANE S.L., FRASER N.W.: During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63, 943-947 (1989).
23. DEVI-RAO G.B., BLOOM D.C., STEVENS J.G., WAGNER E.K.: Herpes simplex virus type 1 DNA replication and gene expression during explant induced reactivation of latently infected murine sensory ganglia. J. Virol. 68, 1271-1282 (1994).
24. DEVI-RAO G.B., AGUILAR J.S., RICE M.K., GARZA H.H. Jr., BLOOM D.C., HILL J.M., WAGNER E.K.: Herpes simplex virus genome replication and transcription during induced reactivation in the rabbit eye. J. Virol. 71, 7039-7047 (1997).
25. DINGWELL K.S., DOERING L.C., JOHNSON D.C.: Glycoproteins E and I facilitate neuron to neuron spread of herpes simplex virus. J. Virol. 69, 7087-7998 (1995).
26. DOBSON A.T., SEDARATI F., DEVI-RAO G., FLANAGAN W.M., FARREL M.J., STEVENS J.G., WAGNER E.K., FELDMAN L.T.: Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 63, 3844-3851 (1989).
27. DOERIG C., PIZER L.I., WILCOX C.L.: An antigen encoded by the latency-associated transcript I neuronal cell cultures latently infected with herpes simplex virus type 1. J. Virol. 65, 2724-2727 (1991).
28. DOUVILLE P., HAGMANN M., GEORGIEV O., SCHAFFNER W.: Positive and negative regulation at the herpes simplex virus ICP4 and ICP0 TAATGARAT motifs. Virology 207, 107-116 (1995).
29. DRESSLER G.R., ROCK D.L., FRASER N.W.: Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. J.Gen. Virol. 68, 1761-1765 (1987).
30. EFSTATHIOU S., MINSON A.C., FIELD H.J., ANDERSON J.R., WILDY P.: Detection of herpes simplex specific DNA sequences in latently infected mice and humans. J. Virol. 57, 446-455 (1986).
31. EVERETT R.D., FREEMONT P., SAITOH H., DASSO M., ORR A., KATHORIA M., PARKINSON J.: The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72, 6581-6591 (1998).
32. EVERETT R.D., MEREDITH M., ORR A.: The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication. J. Virol. 73, 417-26 (1999).
33. FORRESTER A., FARREL H., WILKINSON G., KAYE J., DAVIS-POYNTER N., MINSON T.: Construction and properties of mutant of herpes simplex virus type 1 with gH coding sequences deleted. J. Virol. 66, 341-348 (1992).
34. FRASER N.W., BLOCK T.M., SPIVACK L.G.: The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology 191, 1-8 (1992).
35. FRIDRICH A.J., KLEIM J.P., SCHNEWEIS K.E.: Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction. Arch. Virol. 113, 107-113 (1990).
36. FRUEH K., AHN K., DJABALLAH H., SEMPÉ P., VAN ENDERT P.M., TAMPÉ R.: A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 414-417 (1995).
37. GARBER D.A., SCHAFFER P.A., KNIPE D.M.: A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J. Virol. 71, 5885-5893 (1997).
38. GERSTER T., ROEDER R.G.: A herpesvirus transactivating protein interacts with transcription factor OTF-1 and other cellular proteins. Proc.Nat.Acad.Sci. USA 85, 6347-6351 (1988).
39. COINS W.F., STERNBERG L.R., CROEN K.D., KRAUSE P.R., HENDRICKS R.L., FINK D.J., STRAUS S.E., LEVINE M., GLORIOSO J.C.: A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J. Virol. 68, 2239-2252 (1994).
40. GORDON Y.J., JOHNSON B., ROMANOVSKI E., AURALLO-CRUZ T.: RNA complementary to herpes simplex virus type 1 gene ICP0 demonstrated in neurons of human trigeminal ganglia. J. Virol. 62, 4819-4823 (1988).
41. Gu B., KUDDUS R., DELUCA N.A.: Repression of activation-mediated transcription by herpes simplex virus ICP4 via mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB. Mol.Cell Biol. 15, 3618-3626 (1995).
42. GUPTA R., EMILI A., PAN G., XIAO H., SHALES M., GREENBLATT J., INGLES C.J.: Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB. Nucl.Acids Res. 24, 2324-2330 (1996).
43. HAYWARD G.S.: Immediate-early gene regulation in herpes simplex virus. Semin. Virol. 4, 15-23 (1993).
44. HILL T.J., FIELD H.J., BLYTH W.A.: Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J.Gen. Virol. 28, 341-353 (1975).
45. HILL T.J., BLYTH W.A.: An alternative theory of herpes simplex recurrence and a possible role for prostaglandins. Lancet I, 397-398 (1976).
46. HILL J.M., DUDLEY J.B., SHIMOMURA Y., KAUFMAN H. E.: Quantitation and kinetics of adrenergic induced HSV-1 ocular shedding. Curr.Eye Res. 5, 241-246 (1986).
47. HILL A., JUGOVIC P., YORK I., RUSS G., BENNINK J., YEWDELL J., PLOEGH H., JOHNSON D.: Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415 (1995).
48. HILL J.M., GEBHARDT B.M., WEN R., BOUTERIE A.M., THOMPSON H.W., O'CALLAGHAN R.J., HALFORD W.P., KAUFMAN H.E.: Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 70, 3137-3141 (1996).
49. Ho D.Y.: Herpes simplex virus latency: molecular aspects. Progr.Med. Virol. 39, 76-115 (1992).
50. INGLES C.J.: Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB. Nucl.Acids Res. 24, 2324-2330 (1996).
51. IZUMI K.M., KELVEY A.M., DEVI-RAO G., WAGNER E., STEVENS J.: Molecular and biological characterisation of a type 1 herpes simplex virus specifically deleted for expression of the latency-associated transcript. Microb. Pathogen. 7, 121-134 (1989).
52. JACOBS L.: Glycoprotein E of pseudorabies virus and homologous proteins in other herpesviruses. Arch. Virol. 137, 209-228 (1994).
53. JACOBSON J.G., RUFFNER K.L., KOSZ-VNENCHAK M., HWANG C.B.C., WOBBE K.K., KNIPE D.M., COEN D.M.: Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J. Virol. 67, 6903-6908 (1993).
54. JANG K.L., LATCHMAN D.S.: The herpes simplex virus immediate-early protein ICP27 stimulates the transcription of cellular Alu repeated sequences by increasing the activity of transcription factor TFIIIC. J. Biochem. 284, 667-673 (1992).
55. JINDRAK L., GRUBHOFFER L.: Animal Virus Receptors. Folia Microbiol. 44, 467-486 (1999).
56. JORDAN R., SCHAFFER P.A.: Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J. Virol. 71, 6859-6862 (1997).
57. JORDAN R., PEPE J., SCHAFFER P.A.: Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage. J. Virol. 72, 5373-5382 (1998).
58. KATAN M., HAIGH A., VERRIJZER C.P., VAN DER VLIET P.C., O'HARE P.: Characterization of a cellular factor which interacts functionally with Oct-1 in the assembly of a multicomponent transcription complex. Nucl.Acids Res. 18, 6871-6880 (1990).
59. KAWAGUCHI Y., VAN-SANT C., ROIZMAN B.: Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J. Virol. 71, 7328-7336 (1997a).
60. KAWAGUCHI Y., BRUNI R., ROIZMAN B.: Interaction of herpes simplex virus 1 α regulatory protein ICP0 with elongation factor δ: ICP0 affects translational machinery. J. Virol. 71, 1019-1024 (1997b).
61. KEMP L.M., DENT C.L., LATCHMANN D.S.: Octamer motif mediates transcriptional repression of HSV immediate-early genes and octamer-containing cellular promoters in neuronal cells. Neuron 4, 215-222 (1990).
62. KOSZ-VNENCHAK M., COEN D.M., KNIPE D.M.: Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J. Virol. 64, 5396-5402 (1990).
63. KRAMER M.F., COEN D.M.: Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69, 1389-1399 (1995).
64. KRAMER M F., CHEN S.H., KNIPE D. COEN DM: Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J. Virol. 72, 1177-1185 (1998).
65. KWON SE B., GANGAROSA L.P., BURCH K.D., DEBACK J., HILL J.M.: Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest.Ophthalm. Vis.Sci. 21, 142-149 (1981).
66. KWUN H.J., YIM S.W., LEE D.H., JANG K.L.: Activation of the thymidine kinase promoter by herpes simplex virus type 1 immediate-early proteins. Mol.Cells 9, 277-280 (1999).
67. LACHMANN R.H., SADARANGANI M., ATKINSON H.R., EFSTATHIOU S.: An analysis of herpes simplex virus gene expression during latency establishment and reactivation. J.Gen. Virol. 80, 1271-1282 (1999).
68. LING J.Y., KIENZLE T.E., CHEN T.M., HENKEL J.S., WRIGHT G.C., STROOP W.G.: Comparative analyses of the latency-associated transcript promoters from herpes simplex virus type 1 strains H129, +GC and KOS-63. Virus Res. 50, 95-106 (1997).
69. 4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential α-27 gene. J. Virol. 71, 8602-8614 (1997).
70. 2 terminus of the herpes simplex virus type 1 regulatory protein ICP0 contains a promoter-specific transcription activation domain. J. Virol. 72, 7785-7795 (1998).
71. LOKENSGARD J.R., BERTHOMME H., FELDMAN L.T.: The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency. J. Virol. 71, 6714-6719 (1997).
72. 1 into S phase of the cell cycle. J. Virol. 73, 9456-9467 (1999).
73. LONG M.C., LEONG V., SCHAFFER P.A., SPENCER C.A., RICE S.A.: ICP22 and UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J. Virol. 73, 5593-5604 (1999).
74. MACKEM S., ROIZMAN B.: Regulation herpesvirus macromolecular synthesis: transcription initiation sites and domains of a genes. Proc.Nat.Acad.Sci. USA 77, 7122-7126 (1980).
75. MACKEM S., ROIZMAN B.: Structural features of the α gene 4, 0 and 27 promoter-regulatory sequences which confer α-regulation on chimeric thymidine kinase genes. J. Virol. 44, 939-949 (1982).
76. MADOR N., GOLDENBERG D., COHEN O., PANET A., STEINER I.: Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J. Virol. 72, 5067-5075 (1998).
77. MAGGIONCALDA J., MEHTA A. BAGASRA O., FRASER N.W., BLOCK T.M.: A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics. J.Neurovirol. 2, 268-278 (1996).
78. MARGOLIS T.P., SEDARATI F., DOBSON A.T., FELDMAN L.T. STEVENS J.G.: Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 189, 150-160 (1992).
79. MCGEOCH D.J., DARLYMPLE M.A., DAVISON A.J., DOLAN A., FRAME M.C., MCNAB D., PERRY J.L., SCOTT J.E., TAYLOR P.: The complete DNA sequence of the long unique region in the genome of herpes simplex virus type I. J.Gen. Virol 69, 1531-1574 (1988).
80. MCGREGOR F., PHELAN A., DUNLOP J., CLEMENTS J.B.: Regulation of herpes simplex virus poly(A)-site usage and the action of immediate-early protein IE63 in the early-late switch. J. Virol. 70, 1931-1940, (1996).
81. MCKNIGHT S.L.: Functional relationships between transcriptional control signals of the thymidine kinase gene of herpes simplex virus. Cell 31, 355-365 (1982).
82. MCKNIGHT J.L.C. PELLET P.E., JENKINS F.J. ROIZMAN B.: Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate α-trans-inducing factor dependent activation of α-genes. J. Virol. 84, 7061-7065 (1987).
83. MCMAHAN L., SCHAFFER P.A.: The repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection. J. Virol. 64, 3471-3485 (1990).
84. MINAGAWA H., TANAKA S., TOH Y., MORI R.: Detection of herpes simplex virus type 1-encoded RNA by polymerase chain reaction: different pattern of viral RNA detection in latently infected murine trigeminal ganglia following in vitro or in vivo reactivation. J.Gen. Virol. 75, 647-650 (1994).
85. MISRA V., WALTER S., YANG P., HAYES S., O'HARE P.: Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators. Mol.Cell Biol. 16, 4404-4413 (1996).
86. MITCHELL W.J., STEINER I., BROWN S.M., MACLEAN A.R., SUBAK-SHARPE J.H., FRASER N.W.: A herpes simplex virus type 1 variant deleted in the promoter region of latency associated transcripts, does not produce any detectable minor species during latency in the mouse trigeminal ganglion. J.Gen. Virol. 71, 953-957 (1990).
87. MONTGOMERY R.I., WARNER M.S., LUM B.J., SPEAR P.O.: Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427-436 (1996).
88. MOSSMAN K.L., SMILEY J. R.: Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0. J. Virol. 73, 9726-9733 (1999).
89. NICHOL P.F., CHANG J.Y., JOHNSON E.M., OLIVO P.D.: Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways. J. Virol. 70, 5476-5486 (1996).
90. NSIAH Y.A., RAPP F.: Role of latency-associated transcript in herpes simplex infection. Intervirology 32, 101-115 (1991).
91. O'BRIEN W.J., TSAO L.S., TAYLOR J.L.: Tissue-specific accumulation of latency asscociated transcripts in herpes virus-infected rabbits. Invest.Ophthalm.Vis.Sci. 39, 1847-1853 (1998).
92. O'HARE P., The virion transactivator of herpes simplex virus. Semin. Virol. 4, 145-155 (1993).
93. O'ROURKE D., O'HARE P.: Mutually exclusive binding of two cellular factors within a critical promoter region of the gene for the IE110 protein of herpes simplex virus. J. Virol. 67, 7201-7214 (1993).
94. OGLE W.O., ROIZMAN B.: Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein. J. Virol. 73, 4305-4315 (1999).
95. PAINE T.F.: Latent herpes simplex infection in man. Bacteriol. Rev. 28, 472-479 (1964).
96. PANAGIOTIDIS C.A., LIUM E.K., SILVERSTEIN S.J.: Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27. J. Virol. 71, 1547-1557 (1997).
97. PANDE N.T., PETROSKI M.D., WAGNER E.K.: Functional modules important for activated expression of early genes of herpes simplex virus type 1 are clustered upstream of the TATA box. Virology 246, 145-157(1998).
98. PARKINSON J., LEES-MILLER S.P., EVERETT R.D.: Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J. Virol. 73, 650-657 (1999).
99. PERNG G.C., DUNKEL E.C., GEARY P.A., SLANINA S.M., GHIASI H., KAIWAR R., NESBURN A.B., WECHSLER S.L.: The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol 68, 8045-8055 (1994).
100. PERNG G. C., SLANINA S.M., GHIASI H., NESBURN A.B., WECHSLER S.L.: A 371-nucleotide region between the herpes simplex virus type 1 (HSV-I) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J. Virol. 70, 2014-2018 (1996a).
101. PERNG G.C., CHOKEPHAIBULKIT K., THOMPSON R.L., SAWTELL N.M., SLANINA S.M., GHIASI H., NESBURN A.B., WECHSLER S.L.: The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J. Virol. 70, 282-291 (1996c).
102. PERNG G.C., GHIASI H., SLANINA S. M., NESBURN A. B., WECHSLER S.L.: High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation. J. Virol. 70, 2883-2893 (1996c).
103. PERNG G.C., GHIASI H., SLANINA S.M., NESBURN A.B., WECHSLER S.L.: The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 15 kilobases of the 8.3-kilobase primary transcript. J. Virol. 70, 976-984 (1996d).
104. PHELAN A., CARMO-FONSECA M., MCLAUGHLAN J., LAMOND A.J., CLEMENTS J.B.: A herpes simplex virus type 1 immediate-early gene product, IE 63, regulates small nuclear ribonucleoprotein distribution. Proc.Nat.Acad.Sci. USA 90, 9056-9060 (1993).
105. PHELAN A., DUNLOP J., CLEMENTS J.B.: Herpes simplex virus type 1 protein IE 63 affects the nuclear export of virus intron-containing transcripts. J. Virol. 70, 5255-5265 (1996).
106. PHELAN A., CLEMENTS B.J.: Posttranscriptional regulation in herpes simplex virus. Semin. Virol. 8, 309-318 (1998).
107. PRESTON C. M., NICHOLL M. J.: Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis. J. Virol. 71, 7807-7813 (1997).
108. PRESTON C.M., RINALDI A., NICHOLL M.J.: Herpes simplex virus type 1 immediate-early gene expression is stimulated by inhibition of protein synthesis. J.Gen. Virol. 79, 117-124 (1998).
109. PRESTON C.M.: Repression of viral transcription during herpes simplex virus latency. J.Gen. Virol. 81, 1-9 (2000).
110. PRUIJN G.J., VANDREIL W., VAN DER VLIET P.C.: Nuclear factor III, a novel sequence-specific DNA-binding protein from HeLa cells stimulating adenovirus DNA replication. Nature 322, 656-659 (1986).
111. RAJČANI J., ČIAMPOR F., SABÓ A.: Experimental latent herpesvirus infection in rabbits, mice and hamsters: ultrastructure of virus activation in explanted Gasserian ganglion. Acta Virol. 54, 19-28 (1975).
112. RAJČANI J., SZÁNTÓ J.: The continuing problem of herpes simplex virus persistence. Acta Virol. 27, 442-450 (1983).
113. RAJČÁNI J., VOJVODOVÁ A.: The role of herpes simplex virus glycoproteins in the virus replication cycle. Acta Virol. 42, 103-118 (1998).
114. RAJČÁNI J., KÚDELOVÁ M.: Glykoprotein K of herpes simplex virus: a transmembrane protein encoded by the UL53 gene which regulates membrane fusion. Virus Genes 18, 81-90 (1999).
115. RAJČÁNI J., KÚDELOVÁ M., ORAVCOVÁ I., VOJVODOVÁ A., KOŠOVSKÝ J., MATIS J.: Characterization of strain HSZP of herpes simplex virus type 1 (HSV1). Folia Microbiol. 44, 713-717 (1999).
116. RALPH W.M., CABATINGAN M.S., SCHAFFER P.A.: Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cell after growth arrest release. J. Virol. 68, 6871-6882 (1994).
117. RANDALL G., LAGUNOFF M., ROIZMAN B.: The product of ORF O located within the domain of herpes simplex virus 1 genome transcribed during latent infection binds to and inhibits in vitro binding of infected cell protein 4 to its cognate DNA site. Proc. Nat.Acad.Sci. USA 94, 10379-10384 (1997).
118. RICE S.A., KNIPE D. M.: Genetic evidence for two distinct transactivation functions of the herpes simplex virus α protein ICP27. J. Virol. 64, 1704-1715 (1990).
119. RICE S.A., LAM V.: Amino acid substitution mutations in the herpes simplex virus ICP27 protein define an essential gene regulation function. J. Virol. 68, 823-833 (1994).
120. ROBERTS M.S., BOUNDY A., O'HARE P., PIZZORNO M.C., CIUFO D.M., HAYWARD G.S.: Direct correlation between a negative auto-regulatory response element at the cap site of the herpes simplex virus type 1 IE175 (α 4) promoter and a specific binding site for the IE175 (ICP4) protein. J. Virol. 62, 4307-4320 (1988).
121. ROCK D.I., FRASER N.W: Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302, 523-525 (1983).
122. ROCK D.L., NESBURN A.B., GHIASI H., ONG J., LEWIS T.L., LOKENSGARD J.R., WECHSLER S.L.: Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61, 3820-3826 (1987).
123. ROCK D. L.: Latent infection with bovine herpesvirus type 1. Semin. Virol. 5, 233-240 (1994).
124. ROIZMAN B.: Herpesviridae, pp. 2221-2230 in B.N. Fields, D.M. Knipe, P.M. Howley (Eds): Fields Virology, 3rd ed. Lipincott-Raven, Philadelphia 1996.
125. ROIZMAN B., SEARS A.E.: Herpes simplex viruses and their replication, pp. 1795-1841 in B.N. Fields, D.M. Knipe, P.M. Howley (Eds): Fields Virology, 2nd ed. Lipincott-Raven, Philadelphia 1990.
126. ROIZMAN B., SEARS A.E.: Herpes simplex viruses and their replication, pp. 2231-2295 in B.N. Fields, D.M. Knipe, P.M. Howley (Eds): Fields Virology, 3rd ed. Lipincott-Raven, Philadelphia 1996.
127. RUSS G., ESQUIVEL F., YEWDELL J.W., CRESSWELL P., SPIES T., BENNINK J.R.: Assembly, intracellular localization and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses. J.Biol. Chem. 270, 21312-21318 (1995).
128. RUVKUN G, FINNEY M: Regulation of transcription and cell identity by POU domain proteins. Cell 64, 467-476 (1992).
129. SADOWSKI I., MA, J., TRIEZENBERG S., PTASHNE M.: Gal-4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564 (1988).
130. SAMANIEGO L.A., DELUCA N.: The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected cell survival in the absence of ICP4 and ICP27. J. Virol. 71, 4614-4625 (1997).
131. SAWTELL N.M., THOMPSON R.L.: Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site dependent establishment and reactivation from latency. J. Virol. 66, 2157-2169 (1992).
132. SAWTELL N.M.: Comprehensive quantification of herpes simplex virus latency at the single-cell level. J. Virol. 71, 5423-5431 (1997).
133. SAWTELL N.M., POON D.K., TANSKY C.S., THOMPSON R.L.: The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J. Virol. 72, 5343-5350 (1998a).
134. SAWTELL N.M.: The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol. 72, 6888-6892 (1998b).
135. SEDARATI F., MARGOLIS T.P., STEVENS J.G.: Latent infection can be established with drastically restricted transcription replication of the HSV-1 genome. Virology 192, 687-692 (1993).
136. SCHANG L.M., PHILLIPS J. SCHAFFER P.A.: Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J. Virol. 72, 5626-5637 (1998).
137. SCHANG L.M., ROSENBERG A. SCHAFFER P.A.: Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J. Virol. 73, 2161-2172 (1999).
138. SIMMONS A., SLOBEDMAN B., SPECK P., ARTHUR J., EFSTATHIOU S.: Two patterns of persistence of herpes simplex virus DNA sequence in the nervous systems of latently infected mice. J.Gen. Virol. 73, 1287-1291 (1992).
139. SOARES K., HWANG D.-T., RAMAKRISHNAN R., SCHMID, M.C., FINK D.J., GLORIOSO J.C.: cis-Acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency associated promoter 1 (LAP1) in vitro and in vivo. J. Virol. 70, 5384-5394 (1996).
140. SOLIMAN T.M., SANDRI-GOLDIN R.M., SILVERSTEIN S.J.: Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J. Virol. 71, 9188-9197 (1997).
141. SPEAR P.G.: Entry of alphaherpesviruses into cells. Semin. Virol. 4, 167-180 (1993).
142. SPIVACK J.G., FRASER N.W.: Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J. Virol. 62, 1479-1485 (1988).
143. SPIVACK J.G., FAREED M.U., VALYI-NAGY T., NASH T.C., O'KEEFE J.S.: Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 γ 34,5 mutants in a mouse eye model. J.Gen. Virol. 76, 321-332 (1995).
144. SPIVACK J.G., WOODS G.M., FRASER N.W.: Identification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2 kb LAT. J. Virol. 65, 6800-6810 (1991).
145. STEINER I., SPIVACK J.G., LIRETTE R.P., BROWN M., MCLEAN A.R., SUBAK-SHARPE J.H., FRASER J.W.: Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J. 8, 505-515 (1989).
146. STEPHANOPOULOUS D.E., KAPPES J.C., BERNSTEIN D.I.: Enhanced in vitro reactivation of herpes simplex virus type 2 from latently infected guinea pig neural tissues by 5-azacytidine. J.Gen. Virol. 69, 1079-1083 (1988).
147. STERN S., HERR W.: The herpes simplex virus transactivator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Develop. 5, 2555-2566 (1991).
148. STEVENS J.G., NESBURN A.B., COOK M.L.: Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nature 235, 216-217 (1972).
149. SUBAK-SHARPE J.H., DARGAN D.J.: HSV molecular biology: general aspects of herpes simplex virus molecular biology. Virus Genes 16, 239-251 (1998).
150. TAL-SINGER R., LASNER T.M., PODRZUCKI W., SKOKOTAS A., LEARY J.J., BERGER S.L., FRASER N.W.: Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J. Virol. 71, 5268-5276 (1997).
151. TANAKA S., MINAGAWA H., TOH Y., YING L., MORI R.: Analysis by RNA-PCR of latency and reactivation of herpes simplex virus in multiple neuronal tissues. J.Gen. Virol. 75, 2691-2698 (1994).
152. TATAROWICZ W.A., MARTIN C.E., PEKOSZ A.S., MADDEN S.L, RAUSCHER F.J. 3rd, CHIANG S.Y., BEERMAN T.A., FRASER N.W.: Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J.Neurovirol. 3, 212-224 (1997).
153. TENSER R.B., EDRIS W.A., HAY K.A.: Neuronal control of herpes simplex virus latency. Virology 195, 337-347 (1993).
154. TENSER R.B., HAY K.A., EDRIS W.A.: Latency-associated transcript but not reactivable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1. J. Virol. 63, 2861-2865 (1989).
155. TENSER R.B.: Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency. Intervirology 32, 76-92 (1991).
156. THOMAS S., COFFIN R.S., WATTS P., GOUGH G., LATCHMAN D.S.: The TAATGARAT motif in the herpes simplex virus immediate-early gene promoters can confer both positive and negative responses to cellular octamer-binding proteins when it is located within the viral genome. J. Virol. 72, 3495-3500 (1998).
157. THOMAS S.K., GOUGH G., LATCHMAN D.S., COFFIN R.S.: Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J. Virol. 73, 6618-6625 (1999).
158. UPRICHARD S. L., KNIPE D. M.: Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J. Virol. 70, 1969-1980 (1996).
159. VALYI-NAGY T., DESHMANE S., DILLNER A., FRASER N. W.: Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection and explantation of trigeminal ganglia. J. Virol. 65, 4142-4152 (1991).
160. VOJVODOVÁ A., MATIS J., KÚDELOVÁ M., RAJČÁNI J.: Herpes simplex virus shutoff gene: nucleotide sequence and comparison with HSV strains differing in the early shutoff of host protein synthesis. Virus Genes 15, 155-159 (1997).
161. WAGNER E.K., FLANAGAN W.M., DEVI-RAO G., ZHANG Y.F., HILL J.M., ANDERSON K.P., STEVENS J.G.: The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J. Virol. 62, 4577-4585 (1988).
162. WAHLE E., KELLER W.: The biochemistry of 3′-end cleavage and polyadenylation of mRNA precursors. Ann.Rev Biochem. 61, 419-440 (1992).
163. WHITBECK J.CH., PENG CH., LOU H., XU R., WILLIS S.H., PONCE DE LEON M., PENG T., NICOLA A.V., MONTGOMERY R.I., WARNER M.S., SOULIKA A.M., SPRUCE L.A., MOORE W.T., LAMBRIS J.D., SPEAR P.G., COHEN G.H., EISENBERG R.J.: Glycoprotein D of herpes simplex virus binds directly to HVEM, a member of tumor necrosis factor receptor superfamily and mediator of HSV entry. J. Virol. 71, 6083-6093 (1997).
164. WHITBY A., BLYTH W.A., HILL TJ.: The effect of DNA hypomethylating agents on the reactivation of herpes simplex virus from latently infected mouse ganglia in vitro. Arch. Virol. 97, 137-144 (1988).
165. WHITTON J.L., CLEMENTS J.B.: Replication origins and a sequence involved in coordinate induction of the immediate-early gene family are conserved in an intergenic region of herpes simplex virus. Nucl. Acids Res. 12, 2061-2079 (1984).
166. WILCOX C.L., SMITH R.L., EVERETT R.D., MYSOFSKI D.: The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection. J. Virol. 71, 6777-6785 (1997).
167. WILSON A.C., FREIMAN R.N., GOTO H., NISHIMOTO T., HERR W.: VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol.Cell Biol. 17, 6139-6146 (1997).
168. WU T.T., SU Y.H., BLOCK T.M., TAYLOR J.M.: Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J. Virol. 70, 5962-5967 (1996).
169. XIAO W., PIZER L.I., WILCOX K.W.: Identification of a promoter-specific transaction domain in the herpes simplex virus regulatory protein ICP4. J. Virol. 71, 1757-1765 (1997).
170. ZHI Y., SANDRI-GOLDIN R.M.: Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27. J. Virol. 73, 3246-3257 (1999).
171. ZHI Y., SCIABICA K.S., SANDRI-GOLDIN R.M.: Self-interaction of the herpes simplex virus type 1 regulatory protein ICP27. Virology 257, 341-351 (1999).
172. ZIPSER D., LIPSICH L., KWOH J.: Mapping functional domains in the promoter region of the herpes thymidine kinase gene. Proc.Nat. Acad.Sci.USA 78, 6276-6280 (1981).